"Marcus Neuroscience Institute is staffed by a team of physicians highly trained in all facets of the neurosciences, including stroke, movement disorders, neuro-oncology, memory disorders, Alzheimer’s disease, epilepsy, multiple sclerosis and spinal conditions. The medical staff also includes neurocritical care, neuroradiology and neurointerventional physicians."

During the past decade, Lynn Cancer Institute Marcus Neuroscience Institute conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Lynn Cancer Institute Marcus Neuroscience Institute" are "Adult-type Diffuse Gliomas" (1 trials), "Aggression" (1 trials), "Agitation" (1 trials), "Alzheimer Dementia" (1 trials) and "Dementia" (1 trials). Many other conditions were trialed in "Lynn Cancer Institute Marcus Neuroscience Institute" in a lesser frequency.

Most popular intervention types in "Lynn Cancer Institute Marcus Neuroscience Institute" are "Drug" (3 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "EXPAREL and Bupivacaine" (1 trials), "MP-101" (1 trials), "Optune®" (1 trials), "Pemigatinib" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Lynn Cancer Institute Marcus Neuroscience Institute" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Lynn Cancer Institute Marcus Neuroscience Institute". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Lynn Cancer Institute Marcus Neuroscience Institute, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Lynn Cancer Institute Marcus Neuroscience Institute, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".